Pharmacopoeial Committee of the EAEU as a supranational union has been launched


On the 2nd and 3rd of February, the first meeting of the Pharmacopoeial Committee of the Eurasian Economic Union was held at the site of the Eurasian Economic Commission. It must develop and prepare for the adoption a common Pharmacopeia of the Union, which is the main set of requirements for drugs quality. In a short time, large-scale activities on the approval of the 189 general pharmacopoeia monographs that make up the first volume of the Pharmacopeia of the Union will be held.

Valery Koreshkov, a member of the EEC Board for Technical Regulation, noted the importance of this organisation, which is in fact beginning to form high standards of the Pharmacopeia of the Union taking into account leading international practices. This means that each patient of the EAEU member states is guaranteed to receive safe and high-quality drugs.

Elena Sakanyan, the Chairman of Pharmacopoeial Committee, emphasized that the Pharmacopeia of the Union will become second regional pharmacopoeia in the world after the European Pharmacopoeia. “The combination of pharmacopoeial standards of EAEU states will contribute to the effective development of the Eurasian drugs market,” said the chairman. She also reported that representatives of the European Directorate for the Quality of Medicines and the United States Pharmacopoeia have expressed their intention to participate in the preparation of the Pharmacopoeia of the Eurasian Economic Union as observers.